Parkside Financial Bank & Trust’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
QCM
NAMA
Parkside Financial Bank & Trust's TXG Position: Q2 2026 in Review
Parkside Financial Bank & Trust reduced its 10x Genomics (TXG) stake by 18% in Q2 2026, selling an estimated $3.62K and leaving 610 shares worth $23.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1324.
Parkside Financial Bank & Trust first reported a position in TXG in Q4 2020 and has held it in 23 quarters since. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.
- Parkside Financial Bank & Trust held 610 shares of 10x Genomics worth $23.4K as of Q2 2026.
- Parkside Financial Bank & Trust sold 138 10x Genomics shares in Q2 2026, an estimated $3.62K.
- 10x Genomics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1324 holding.
- Parkside Financial Bank & Trust first reported a position in 10x Genomics in Q4 2020 and has held it in 23 quarters since.
- 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.